Physical, Functional and Neural Effects of Two Lower Extremity Exercise Protocols in Children With Cerebral Palsy

NCT01086670 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2022-03-29

No results posted yet for this study

Summary

Background:

* Many people who have cerebral palsy (CP) have spastic diplegia, which affects the legs and causes difficulty with leg movement and walking. Research has shown that exercise can help those with CP learn to move their arms better, but more research is needed to determine whether exercise programs can improve leg movements in people with CP.
* Walking on a treadmill with the help of a physical therapist has improved the treatment outcomes of some individuals with spinal cord injuries. Many children with CP already have physical therapy but still have trouble with walking and leg coordination. Two other kinds of exercise machines, a stationary bicycle and an elliptical machine, used in the home, may be able to help children with CP walk better and move their legs better.

Objectives:

* To see how children with cerebral palsy (CP) move their legs differently from children without CP.
* To see if an exercise program can improve leg coordination in children with CP.

Eligibility:

\- Children between 5 and 17 years of age who either have spastic diplegia CP or are healthy volunteers.

Design:

* Children who are able and willing will have magnetic resonance imaging (MRI) scans at the start and the end of the study.
* During Part I of the study, participants will demonstrate their leg and muscle function with the following tests:
* Measurement of leg size and movement
* Combined camera motion study and electrical impulse evaluation to assess how well the participant walks (with or without an assistive device, as needed)
* Leg movement tests on an exercise bicycle and elliptical machine
* Tests of leg muscle strength, stiffness, and effectiveness
* Ultrasound scans of leg muscle
* Parents of participants will complete computer-based questionnaires about their child s motor abilities.
* A smaller group of participants will continue to Part II of the study, which involves regular exercise of 20 minutes a day, 5 days a week, for 3 months, on a stationary bicycle or elliptical trainer. Half of the group will start this exercise program immediately after the first part of the study, while the other half will wait 3 months before beginning the exercise program.
* During Part II, participants will return to the clinical center for two more sets of the tests and evaluations performed in Part I.

Conditions

  • Cerebral Palsy
  • Children
  • Adolescents

Interventions

OTHER

Physical Exercise

Children will be assigned either an elliptical machine or cycle to take home. Each exercise will be performed for 20 minutes per day, 5 days per week for a period of 12 consecutive weeks, or 60 sessions in all. To avoid excessive fatigue or over-training effects, children are asked to adhere to this exact schedule and not to exercise more than this. Children are asked to complete as many of the sessions as they can. To allow for sick days or vacation during the program, the duration of the training can be extended up to 2 more weeks if needed to try to complete all 60 sessions. Compliance (percent sessions completed) will be correlated with outcomes in the statistical analyses.

Sponsors & Collaborators

  • National Institutes of Health Clinical Center (CC)

    lead NIH

Principal Investigators

  • Diane L Damiano, Ph.D. · National Institutes of Health Clinical Center (CC)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-30
Primary Completion
2015-01-12
Completion
2016-05-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01086670 on ClinicalTrials.gov